Synthesis and preliminary characterization of sulfamethazine-theophylline co-crystal

Journal of Pharmaceutical Sciences

Volumn 99, Issue 9, 2010, Pages 4042-4047

  Lu, Jie ^a   Rohani, Sohrab ^b  

^a JIANGNAN UNIVERSITY   (China)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Characterization; Co crystal; Sulfamethazine; Synthesis; Theophylline

Indexed keywords

SULFADIMIDINE; THEOPHYLLINE;

ARTICLE; CRYSTAL; DRUG STRUCTURE; DRUG SYNTHESIS; EVAPORATION; GRINDING; HYDROGEN BOND; SOLID STATE; SPECTROSCOPY; THERMAL ANALYSIS; X RAY DIFFRACTION;

EID: 77956384238     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22142     Document Type: Article

References (31)

1. Vishweshwar P, McMahon JA, Bis JA, Zaworotko MJ. 2006. Pharmaceutical co-crystal. J Pharm Sci 95:499-516.
2. Aitipamula S, Chow PS, Tan RBH. 2009. Dimorphs of a 1:1 cocrystal of ethenzamide and saccharin: Solid-state grinding methods result in metastable polymorph. Cryst Eng Comm 11:889-895.
3. Shan N, Zaworotko MJ. 2008. The role of cocrystals in pharmaceutical science. Drug Discov Today 13:440-446.
4. Babu NJ, Reddy LS. Nangia A. 2007. Amide-N-oxide heterosynthon and amide dimer homosynthon in cocrystals of carboxamide drugs and pyridine N-oxides. Mol Pharm 4:417-434. (Pubitemid 46983957)
5. Childs SL, Hardcastle KI. 2007. Cocrystals of piroxicam with carboxylic acids. Cryst Growth Des 7:1291-1304.
6. Bučar DK, Henry RF, Lou XC, Duerst RW, Borchardt TB, MacGillivray LR, Zhang GGZ. 2007. Co-crystals of caffeine and hydroxy-2-naphthoic acids: Unusual formation of the carboxylic acid dimer in the presence of a heterosynthon. Mol Pharm 4:339-346.
7. Fernandez-Lopez S, Kim HS, Choi EC, Delgado M, Granja JR, Khasanov A, Kraehenbuehl K, Long G, Weinberger DA, Wilcoxen KM, Ghadiri MR. 2001. Antibacterial agents based on the cyclic D,L-alpha-peptide architecture. Nature 412:452-455.
8. Shattock TR, Arora KK, Vishweshwar P, Zaworotko MJ. 2008. Hierarchy of supramolecular synthons: Persistent carboxylic acid - Pyridine hydrogen bonds in cocrystals that also contain a hydroxyl moiety. Cryst Growth Des 8:4533-4545.
9. Hickey MB, Peterson ML, Scoppettuolo LA, Morrisette SL, Vetter A, Guzmán H, Remenar JF, Zhang Z, Tawa MD, Haley S, Zaworotko MJ, Almarsson Ö. 2007. Performance comparison of a co-crystal of carbamazepine with marketed product. Eur J Pharm Biopharm 67:112-119.
10. Chadwick K, Davey R, Cross W. 2007. How does grinding produce co-crystals? Insights from the case of benzophenone and diphenylamine. Cryst Eng Comm 9:732-734.
11. Palmer DS, Llinàs A, Morao I, Day GM, Goodman JM, Glen RC, Mitchell JBO. 2008. Predicting intrinsic aqueous solubility by a thermodynamic cycle. Mol Pharm 5:266-279. (Pubitemid 351579130)
12. Seefeldt K, Miller J, Alvarez-Núñez F, Rodríguez- Hornedo N. 2007. Crystallization pathways and kinetics of carbamazepinenicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies. J Pharm Sci 96:1147-1158.
13. Zhang GGZ, Henry RF, Borchardt TB, Lou XC. 2007. Efficient co-crystal screening using solution-mediated phase transformation. J Pharm Sci 96:990-995.
14. Bučar DK, Henry RF, Lou XC, Duerst RW, MacGillivray LR, Zhang GGZ. 2009. Cocrystals of caffeine and hydroxybenzoic acids composed of multiple supramolecular heterosynthons: Screening via solution-mediated phase transformation and structural characterization. Cryst Growth Des 9:1932-1943.
15. Bis JA, Vishweshwar P, Middleton RA, Zaworotko MJ. 2006. Concomitant and conformational polymorphism, conformational isomorphism, and phase relationships in 4-cyanopyridine·4,4′-biphenol cocrystals. Cryst Growth Des 6:1048-1053.
16. Fleishman SG, Kuduva SS, McMahon JA, Moulton B, Walsh RDB, Rodríguez-Hornedo N, Zaworotko MJ. 2003. Crystal engineering of the composition of pharmaceutical phases: Multiple- component crystalline solids involving carbamazepine. Cryst Growth Des 3:909-919. (Pubitemid 37474229)
17. Reddy LS, Bhatt PM, Banerjee R, Nangia A, Kruger GJ. 2007. Variable-temperature powder X-ray diffraction of aromatic carboxylic acid and carboxamide cocrystals. Chem Asian J 2:505-513.
18. Shan N, Toda F, Jones W. 2002. Mechanochemistry and cocrystal formation: Effect of solvent on reaction kinetics. Chem Commun 2372-2373.
19. Friščić T, Trask AV, Jones W, Motherwell WDS. 2006. Screening for inclusion compounds and systematic construction of three-component solids by liquid-assisted grinding. Angew Chem Int Ed 45:7546-7550.
20. Friščić T, Trask AV, Motherwell WDS, Jones W. 2008. Guestdirected assembly of caffeine and succinic acid into topologically different heteromolecular host networks upon grinding. Cryst Growth Des 8:1605-1609.
21. van Andel AE, Reisner C, Menjoge SS, Witek TJ. 1999. Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995. Chest 115:703-707.
22. Trask AV, Motherwell SWD, Jones W. 2006. Physical stability enhancement of theophylline via cocrystallization. Int J Pharm 320:114-123. (Pubitemid 44128714)
23. Childs SL, Stahly GP, Park A. 2007. The salt-cocrystal continuum: The influence of crystal structure on ionization state. Mol Pharm 4:323-338.
24. Caira MR. 1992. Molecular complexes of sulfonamides. 2.1:1 complexes between drug molecules: Sulfadimidine-acetylsalicylic acid and sulfadimidine-4-aminosalicylic acid. J Crystallogr Spectrosc Res 22:193-200.
25. Caira MR. 2007. Sulfa drugs as model cocrystal formers. Mol Pharm 4:310-316.
26. Maury L, Rambaud J, Pauvert B, Lasserre Y, Bergé G, Audran M. 1985. Physicochemical and structural study of sulfamethazine. J Pharm Sci 74:422-426.
27. Madarász J, Bombicz P, Jármi K, Bán M, Pokol G, Gál S. 2002. Thermal, FTIR and XRD study on some 1:1 molecular compounds of theophylline. J Therm Anal Calorim 69:281-290.
28. Bán M, Madarász J, Bombicz P, Pokol G, Gál S. 2002. Thermal and structural study on the lattice compound 1,4-diammoniumbutane bis(theophyllinate). Thermochim Acta 420:105-109.
29. Nolasco MM, Amado AM, Ribeiro-Claro PJA. 2006. Computationally-assisted approach to the vibrational spectra of molecular crystals: Study of hydrogen-bonding and pseudopolymorphism. Chem Phys Chem 7:2150-2161.
30. Sutherland WS, Laserna JJ, Angebranndt MJ, Winefordner JD. 1990. Surface-enhanced Raman analysis of sulfa drugs on colloidal silver dispersion. Anal Chem 62:689-693.
31. Nishijo J, Ohno K, Nishimura K. 1982. Interaction of theophylline with benzylamine in the solid state. Chem Pharm Bull 30:2219-2222. (Pubitemid 13231896)